Tirzepatide, sold under the brand name Mounjaro (for diabetes) and Zepbound (for weight loss), is a newer medication that targets two hormones instead of just one
Insurance coverage does not automatically follow
Ideal candidates typically have a BMI of 30 or higher, or a BMI of 27 or higher with additional health concerns such as high blood pressure, type 2 diabetes, or high cholesterol
Research areas include tissue repair mechanisms, angiogenesis, cytoprotection, and interaction with the nitric oxide system
Maximum doses are safety ceilings, not goals, and many patients see results without reaching the highest dose
Peptidet er i dag ansett som et av de mest lovende verktyene innen regenerativ medisin og hudhelse